Washington, D.C. – ACLA issued the following statement in response to delayed Congressional action to replenish the depleted COVID-19 Uninsured Relief Fund: “ACLA is committed ... Read More
Washington, D.C. – ACLA Board Chair William G. Morice, MD, PhD, and President of Mayo Clinic Laboratories, today announced the Board’s selection of Susan Van Meter ... Read More
WASHINGTON, D.C. – Following the Senate confirmation of Robert Califf, M.D. as Commissioner of the U.S. Food and Drug Administration (FDA), the American Clinical Laboratory ... Read More
Washington, D.C. – As cases of COVID-19 continue to surge across the country amid the current Omicron wave, ACLA issued the following statement: “Since the outset of ... Read More
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) applauds the passage of S. 610, the Protecting Medicare and American Farmers from Sequester Cuts Act, paving the way for renewed ... Read More
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed the bipartisan and bicameral agreement to safeguard seniors’ access to lifesaving clinical laboratory services in the ... Read More
WASHINGTON, D.C. – With millions of seniors facing decreased access to lab services as a result of cuts to nearly 600 lab tests, nearly 30 leading ... Read More
Following the announcement from U.S. Department of Health and Human Services Secretary Xavier Becerra regarding regulation and review of laboratory developed tests (LDTs), ACLA President ... Read More
Following the Biden Administration’s announcement regarding two new federal rules on COVID-19 vaccination, ACLA President Julie Khani released the following statement: “We welcome the Biden ... Read More
Washington, D.C. – ACLA Board Chair William G. Morice, MD, PhD, and President of Mayo Clinic Laboratories, released the following statement on the forthcoming departure of ... Read More
